Cargando…

Optimizing the implementation of future treatment using surrogate end-points

Detalles Bibliográficos
Autor principal: Dowsett, Mitch
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614852/
https://www.ncbi.nlm.nih.gov/pubmed/19128440
http://dx.doi.org/10.1186/bcr2186
_version_ 1782163253977153536
author Dowsett, Mitch
author_facet Dowsett, Mitch
author_sort Dowsett, Mitch
collection PubMed
description
format Text
id pubmed-2614852
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26148522009-01-08 Optimizing the implementation of future treatment using surrogate end-points Dowsett, Mitch Breast Cancer Res Short Communication BioMed Central 2008 2008-12-18 /pmc/articles/PMC2614852/ /pubmed/19128440 http://dx.doi.org/10.1186/bcr2186 Text en Copyright © 2008 BioMed Central Ltd
spellingShingle Short Communication
Dowsett, Mitch
Optimizing the implementation of future treatment using surrogate end-points
title Optimizing the implementation of future treatment using surrogate end-points
title_full Optimizing the implementation of future treatment using surrogate end-points
title_fullStr Optimizing the implementation of future treatment using surrogate end-points
title_full_unstemmed Optimizing the implementation of future treatment using surrogate end-points
title_short Optimizing the implementation of future treatment using surrogate end-points
title_sort optimizing the implementation of future treatment using surrogate end-points
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614852/
https://www.ncbi.nlm.nih.gov/pubmed/19128440
http://dx.doi.org/10.1186/bcr2186
work_keys_str_mv AT dowsettmitch optimizingtheimplementationoffuturetreatmentusingsurrogateendpoints